Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers

Update: 2024-11-27

Description

The latest epiosde of Optimum Perspectives Podcast features Germo Gericke, CMO of Ariceum Therapeutics. Listen as he discusses how the company aims to improve outcomes for patients with lung cancer with radioligand therapy this Lung Cancer Awareness Month.

Hosted on Acast. See acast.com/privacy for more information.

Comments

In Channel

Tackling the threat of AMR

2025-11-1331:21

The ups and downs of ADCs – where to now?

2025-11-0329:44

Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease

2025-08-0523:15

Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025

2025-06-2524:23

Stronger together: changing the future of muscle wasting condition

2025-02-2829:45

How bioengineered spider silk-based proteins are changing the world

2025-02-0612:14

How to have a perfect IPO on NASDAQ

2025-01-2323:53

Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers

2024-11-2709:58

Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer

2024-11-2109:17

DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

2024-11-0515:51

SpliceBio: Celebrating progress in ophthalmology research on World Sight Day

2024-10-1011:42

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

2024-09-1214:24

Resolution Therapeutics: pioneering macrophage therapies for liver diseases

2024-08-0827:55

Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader

2024-07-2521:42

How AI is revolutionising drug research

2024-05-3023:39

Curve Therapeutics – Addressing challenging drug targets

2024-05-2312:39

Biotech IPOs make a comeback in 2024

2024-05-1620:55

Anglonordic Life Science Conference strikes optimistic note for ‘24

2024-05-0709:12

The challenges of recruitment for clinical trials

2024-04-0424:16

Lytix Biopharma – Innovations in Killing Cancer

2024-03-0717:07

00:00

1.0x

Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers

#box-pro-ellipsis-176507263819321{-webkit-line-clamp:2;}Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers

Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers

Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers